SEC Form 4 · accession 0001567619-19-006155
Medpace Holdings, Inc. · MEDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
August J. Troendle
Officer — President & CEO · Director · 10% Owner
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001668397
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 603,702 | D | ||
| Common StockF1 | holding | — | — | — | 7,751,125 | I | By Medpace Investors, LLC | |
| Common Stock | holding | — | — | — | 10,000 | I | By son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $54.74 | Mar 1, 2019 | A | 77,417 | A | — | Mar 1, 2026 | Common Stock | 77,417 | 77,417 | D |
Explanation of responses
- F1The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the shares held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F2The option vests immediately upon issuance.